Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Leckrone Entanglement

You would rather all the leverage be in the hands of TPL? So they can package their other licenses with MPP discounts?

The best use of shareholder funds that I can think of right now would be for PTSC to take control of existing and future reverse engineering documentation and the associtated licensing activities that go along with it. TPL has no fiduciary duty to PTSC share holders. PTSC does.

Share
New Message
Please login to post a reply